Pain reliever Aspirin - a double-edged sword for cancer prevention

Daily use of aspirin analgesics is believed to help limit the risk of certain cancers, including intestinal cancer.

However, a study published on September 6 in Royal Society Interface Magazine suggests that this risk causes cancer, if acquired, to become more difficult to treat.

A recent study has shown that daily use of aspirin in extremely small doses for at least five years may prevent the risk of cancer at the end of life. Accordingly, the incidence of prostate, nasopharynx and lung cancer is significantly reduced, especially the incidence of intestinal cancer decreases by 50%.

Aspirin increases the ability to create resistant cells in tumors.

However, further studies show that aspirin increases the ability of the tumor to produce resistant cells , making it difficult to treat cancer.

The results come after researchers at the University of California in Irvine continued to work on whether this pain medication caused dangerous complications of cancer.

The study authors added that it is important to make sure aspirin delays the onset of colorectal cancer for a long time to avoid the negative effects of this drug. Therefore, people who take aspirin, especially in middle age, are recommended for regular screening for cancer.

According to statistics, about 50% of adults in the United States take about 80-325 milligrams of aspirin daily to prevent cardiovascular disease. In the UK, this number is about 40%